| Companies sponsors |
Eli Lilly (selpercatinib) |
| Others |
Department of Health and Social Care |
| |
NHS England |
| Professional groups |
Association of Cancer Physicians |
| |
British Thoracic Oncology Group |
| |
Cancer Research UK |
| |
Royal College of Physicians |
| |
Royal College of Radiologists |
| Assessment group |
Institute of Cancer Research |
| Comparator companies |
Accord Healthcare (cisplatin, carboplatin, docetaxel, gemcitabine, paclitaxel, vinorelbine) – confidentiality agreement not signed, not participating |
| |
Boehringer Ingelheim (nintedanib) – confidentiality agreement not signed, not participating |
| |
Bristol-Myers Squibb (nivolumab) – confidentiality agreement not signed, not participating |
| |
Celgene (paclitaxel, nab-paclitaxel) – confidentiality agreement not signed, not participating |
| |
Consilient Health Ltd (carboplatin, vinorelbine) – confidentiality agreement not signed, not participating |
| |
Dr Reddy’s Laboratories (docetaxel, pemetrexed) – confidentiality agreement not signed, not participating |
| |
Fresenius Kabi (docetaxel, paclitaxel) – confidentiality agreement not signed, not participating |
| |
Fresenius Kabi Oncology (carboplatin, gemcitabine) – confidentiality agreement not signed, not participating |
| |
Hospira UK (cisplatin, carboplatin, docetaxel, gemcitabine, paclitaxel) – confidentiality agreement not signed, not participating |
| |
Medac GmbH (vinorelbine) – confidentiality agreement not signed, not participating |
| |
Merck Sharp & Dohme (pembrolizumab) |
| |
Pfizer (carboplatin, cisplatin, docetaxel, gemcitabine, paclitaxel) – confidentiality agreement not signed, not participating |
| |
Pierre Fabre Ltd (vinorelbine) – confidentiality agreement not signed, not participating |
| |
Roche Products (atezolizumab, bevacizumab, erlotinib) – confidentiality agreement not signed, not participating |
| |
Sandoz Ltd (cisplatin) – confidentiality agreement not signed, not participating |
| |
Sanofi (docetaxel) – confidentiality agreement not signed, not participating |
| |
Seacross Pharmaceuticals (docetaxel, paclitaxel) – confidentiality agreement not signed, not participating |
| |
Sun Pharma (carboplatin, gemcitabine) – confidentiality agreement not signed, not participating |
| |
Teva UK (carboplatin, cisplatin, docetaxel, paclitaxel) – confidentiality agreement not signed, not participating |
| General commentators |
All Wales Therapeutics and Toxicology Centre |
| |
British National Formulary |
| |
Department of Health, Social Services and Public Safety for Northern Ireland |
| |
Healthcare Improvement Scotland |
| |
Medicines and Healthcare products Regulatory Agency |
| |
Scottish Medicines Consortium |
| |
Welsh Government |
| |
Welsh Health Specialised Services Committee |